{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:05:19Z","timestamp":1763625919192,"version":"3.45.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.resinv.2025.10.003","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T03:33:31Z","timestamp":1760672011000},"page":"1274-1278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of the serum neutrophil-to-lymphocyte ratio in patients with lung cancer undergoing pleurodesis during best supportive care: A retrospective cohort study"],"prefix":"10.1016","volume":"63","author":[{"given":"Kosuke","family":"Dobashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5718-5120","authenticated-orcid":false,"given":"Yasutaka","family":"Hirasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4008-3475","authenticated-orcid":false,"given":"Kazuko","family":"Miyakawa-Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Imura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9894-5216","authenticated-orcid":false,"given":"Shinichi","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7669-7892","authenticated-orcid":false,"given":"Ichiro","family":"Inoshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2025.10.003_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/16000617.0019-2016","article-title":"Malignant pleural effusion: from bench to bedside","volume":"25","author":"Psallidas","year":"2016","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.resinv.2025.10.003_bib2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/resp.12496","article-title":"Clinical features and survival of lung cancer patients with pleural effusions","volume":"20","author":"Porcel","year":"2015","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2025.10.003_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1186\/s12885-017-3550-8","article-title":"Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.resinv.2025.10.003_bib4","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1007\/s13304-024-01985-2","article-title":"Comparison of five scores to predict mortality in malignant pleural effusion","volume":"76","author":"Ayik T\u00fcrk","year":"2024","journal-title":"Updates Surg"},{"key":"10.1016\/j.resinv.2025.10.003_bib5","first-page":"47","article-title":"Prognostic factors for short\u2010term survival in patients with stage IV non\u2010small cell lung cancer","volume":"3","author":"Ando","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.resinv.2025.10.003_bib6","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1183\/09031936.00069812","article-title":"Survival of lung adenocarcinoma patients with malignant pleural effusion","volume":"41","author":"Wu","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2025.10.003_bib7","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2017.17426","article-title":"Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial","volume":"318","author":"Thomas","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2025.10.003_bib8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.chest.2016.11.010","article-title":"US hospitalizations for malignant pleural effusions: data from the 2012 National Inpatient Sample","volume":"151","author":"Taghizadeh","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2025.10.003_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00349-2018","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"52","author":"Bibby","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2025.10.003_bib10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. An official ATS\/STS\/STR clinical practice guideline","volume":"198","author":"Feller-Kopman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.10.003_bib11","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial","volume":"307","author":"Davies","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2025.10.003_bib12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/thorax-2023-220304","article-title":"British thoracic society guideline for pleural disease","volume":"78","author":"Roberts","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2025.10.003_bib13","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score","volume":"69","author":"Clive","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2025.10.003_bib14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s40001-025-02595-3","article-title":"Neutrophil-to-lymphocyte ratio as a prognostic marker for lung cancer in combined pulmonary fibrosis and emphysema patients","volume":"30","author":"Jin","year":"2025","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.resinv.2025.10.003_bib15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.21037\/tlcr-24-675","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in second-line immunotherapy for patients with non-small cell lung cancer","volume":"14","author":"Knetki-Wr\u00f3blewska","year":"2025","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.resinv.2025.10.003_bib16","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1186\/s12885-025-13811-y","article-title":"Neutrophil-to-lymphocyte ratio-based prognostic score can predict outcomes in patients with advanced non-small cell lung cancer treated with immunotherapy plus chemotherapy","volume":"25","author":"Liao","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.resinv.2025.10.003_bib17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12672-025-02391-9","article-title":"Prognostic value of combined nutritional and inflammatory markers in NSCLC patients receiving ICIs","volume":"16","author":"Liu","year":"2025","journal-title":"Discov Oncol"},{"key":"10.1016\/j.resinv.2025.10.003_bib18","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3390\/biom13121803","article-title":"Neutrophil-to-lymphocyte ratio (NLR) in NSCLC, gastrointestinal, and other solid tumors: immunotherapy and beyond","volume":"13","author":"Mosca","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.resinv.2025.10.003_bib19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/1055-9965.EPI-23-1145","article-title":"White blood cell count, neutrophil-to-lymphocyte ratio, and incident cancer in the UK biobank","volume":"33","author":"Song","year":"2024","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.resinv.2025.10.003_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40425-019-0549-5","article-title":"Lymphopenia in cancer patients and its effects on response to immunotherapy: an opportunity for combination with cytokines?","volume":"7","author":"M\u00e9n\u00e9trier-Caux","year":"2019","journal-title":"J Immunotherap Cancer"},{"key":"10.1016\/j.resinv.2025.10.003_bib21","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/carcin\/bgl250","article-title":"Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer","volume":"28","author":"Zhang","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.resinv.2025.10.003_bib22","first-page":"947","article-title":"Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma","volume":"7","author":"Dworacki","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.resinv.2025.10.003_bib23","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1172\/JCI3784","article-title":"CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs","volume":"102","author":"Agrawal","year":"1998","journal-title":"J Clin Investig"},{"key":"10.1016\/j.resinv.2025.10.003_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12885-022-09628-8","article-title":"Prognostic value of CD4+ T lymphopenia in non-small cell lung cancer","volume":"22","author":"Eberst","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.resinv.2025.10.003_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12672-023-00793-1","article-title":"Regulation of T cells by myeloid-derived suppressor cells: emerging immunosuppressor in lung cancer","volume":"14","author":"He","year":"2023","journal-title":"Discov Oncol"},{"key":"10.1016\/j.resinv.2025.10.003_bib26","article-title":"Lymphocyte-to-C-reactive protein ratio predicts prognosis in unresectable locally advanced non-small cell lung cancer patients","volume":"57","author":"Xu","year":"2025","journal-title":"Ann Med"},{"key":"10.1016\/j.resinv.2025.10.003_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13287-016-0377-1","article-title":"C-reactive protein can upregulate VEGF expression to promote ADSC-induced angiogenesis by activating HIF-1\u03b1 via CD64\/PI3k\/Akt and MAPK\/ERK signaling pathways","volume":"7","author":"Chen","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.resinv.2025.10.003_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12931-019-1204-x","article-title":"Chemical pleurodesis\u2013a review of mechanisms involved in pleural space obliteration","volume":"20","author":"Mierzejewski","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2025.10.003_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1183\/09031936.03.00086202","article-title":"Transforming growth factor\u2010\u03b2 induces collagen synthesis without inducing IL\u20108 production in mesothelial cells","volume":"22","author":"Lee","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2025.10.003_bib30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J Natl Cancer Inst"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525001625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525001625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:00:32Z","timestamp":1763625632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534525001625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2212534525001625"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2025.10.003","relation":{},"ISSN":["2212-5345"],"issn-type":[{"type":"print","value":"2212-5345"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of the serum neutrophil-to-lymphocyte ratio in patients with lung cancer undergoing pleurodesis during best supportive care: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2025.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}